Results 11 to 20 of about 3,494 (189)

Health-related preferences of older patients with multimorbidity: an evidence map [PDF]

open access: yesBMJ Open, 2019
Objectives To systematically identify knowledge clusters and research gaps in the health-related preferences of older patients with multimorbidity by mapping current evidence.Design Evidence map (systematic review variant).Data sources MEDLINE, EMBASE ...
Marjan Van Den Akker   +11 more
doaj   +3 more sources

Interrupted Time Series Analysis of Alcohol Use Disorder Treatment Utilisation During the Coronavirus Pandemic in Hamburg, Germany. [PDF]

open access: yesDrug Alcohol Rev
ABSTRACT Introduction Alcohol use and treatment for alcohol use disorder (AUD) changed during the pandemic. Alcohol consumption increased among high‐risk groups, while treatment utilisation declined, raising concerns about an expanding treatment gap. This study analyses inpatient and outpatient AUD treatment trends during the pandemic.
Manthey J   +4 more
europepmc   +2 more sources

Implikation von Datenschnitten und Zensierung in klinischen Studien auf die Bewertbarkeit von Arzneimitteln

open access: yesMonitor Versorgungsforschung, 2021
Kommentar von Dr. PH Dipl.-Stat. Carsten Schwenke (SCO:SSiS Statistical Consulting, Berlin).
Dr. PH Dipl.-Stat. Carsten Schwenke
doaj   +1 more source

Competence-based catalog of learning objectives for the subject area of quality management in medical studies – position paper of the working group Quality Management in Education, Training and Continuing Education of the Society for Quality Management in Health Care (GQMG)

open access: yesGMS Journal for Medical Education, 2023
Background: Traditionally, direct medical competences are taught in medical studies, whereas leadership and quality management competences are hardly taught, although graduates are already confronted with management tasks at the beginning of their ...
Vogeser, Michael   +7 more
doaj   +1 more source

Die „Target Trial Emulation“ zu CAR-T im AMNOG

open access: yesMonitor Versorgungsforschung, 2023
Das Konzept „Target Trial Emulation“ sowie propensity score-basierte Adjustierungsverfahren sind empfohlene Methoden, um in indirekten Vergleichen ohne Brückenkomparator systematische Verzerrung zu minimieren. Anhand des Vergleichs der einarmigen Evidenz
Janine Jakobs BS MS   +3 more
doaj   +1 more source

Förderung muss weit voraus in die Zukunft denken

open access: yesMonitor Versorgungsforschung, 2023
"In der Phase, in der wir über eine Verstetigung des Innovationsfonds nachdenken, bedarf es einer kritischen Reflexion auf allen Seiten“. Das sagte Prof.
Peter Stegmaier
doaj   +1 more source

Health-related preferences of older patients with multimorbidity: the protocol for an evidence map [PDF]

open access: yes, 2019
Introduction: Interaction of conditions and treatments, complicated care needs and substantial treatment burden make patient–physician encounters involving multimorbid older patients highly complex.
Blom, Jeanet   +12 more
core   +1 more source

Quality contract ‘prevention of postoperative delirium in the care of elderly patients’ study protocol: a non-randomised, pre–post, monocentric, prospective trial

open access: yesBMJ Open, 2023
Introduction Postoperative delirium (POD) is seen in approximately 15% of elderly patients and is related to poorer outcomes. In 2017, the Federal Joint Committee (Gemeinsamer Bundesausschuss) introduced a ‘quality contract’ (QC) as a new instrument to ...
Sascha Treskatsch   +28 more
doaj   +1 more source

Jurisdictions on the reimbursement of new medical technologies by public health insurance: A systematic review [PDF]

open access: yes, 2018
Hintergrund: Die Erstattung neuer Gesundheitstechnologien wird nicht selten über Sozialgerichte eingeklagt. Dabei liegt es nahe, dass gerichtliche Entscheidungen auch Einzelfallentscheidungen der Krankenkassen und damit den Patientenzugang insgesamt ...
Ex, Patricia   +2 more
core   +1 more source

Auswirkungen der neuen Dossieranforderungen

open access: yesMonitor Versorgungsforschung, 2023
Bei Markteintritt oder Zulassungserweiterung eines neuen Arzneimittels sind pharmazeutische Unternehmer in Deutschland seit 2011 zur Einreichung eines AMNOG-Nutzendossiers beim G-BA verpflichtet.
Dr. rer. nat. Maria Katharina Schweitzer   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy